mRNA Technology demonstrated its enormous potential during the COVID-19 pandemic – not only as a rapid and highly adaptable approach to vaccine development, but also as a promising platform for innovative therapies in oncology, immunology, and personalized medicine.

One of the greatest challenges in manufacturing mRNA-based products is preventing the degradation of these sensitive molecules during production, purification, and formulation through to final application. PAN-Biotech provides RNase-free solutions that ensure RNA integrity at every stage of the process – from upstream to downstream – for reliability, consistency, and high-quality results.